The National Institutes of Health (NIH) announces the continuation of the U.S. entity of the U.S.-Japan Brain Research Cooperative Program (BRCP). This administrative supplement program will provide funds to currently active research grants that are currently supported by one of the participating NIH Institutes and Centers. This Notice is soliciting administrative supplements for the following mechanisms ONLY: DP1, DP2, DP5, R00, R01, R03, R21, R33, R34, R35, R37, R61, RM1, U01, UH2, and UH3.
The purpose of the BRCP is to promote scientist exchange, training, and collaborations in basic, translational and clinical research between neuroscientists from the U.S. and Japan.
The U.S. entity of the BRCP supports the following activities:
1) Visit of U.S. scientists to conduct collaborative research and/or to acquire advanced research skills at institutions in Japan.
2) Joint workshops to exchange scientific information and to foster collaborations.
Application Due Date(s) – September 18, 2023, September 18, 2024, September 18, 2025
NOT-NS-23-092
Individual(s) must hold an active grant award from one of the participating NIH Institutes or Centers. For supplements to parent awards that include multiple PDs/PIs, the supplement may be requested by any or all of the PDs/PIs (in accordance with the existing leadership plan) and must be submitted by the awardee institution of the parent award.
New and early stage investigators are encouraged to apply, as well as established neuroscientists. Individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and women are always encouraged to apply for NIH support. See: NOT-OD-20-031
